Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast CancerSaverio Cinieri, Uğur Çoşkun, Patricia Dodyk et al.|Clinical Breast Cancer|2016Cited by 12
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial).Saverio Cinieri, Uğur Çoşkun, Arlene Chan et al.|Journal of Clinical Oncology|2014Cited by 3
Osteonecrosis of the jaw: Long-term follow-up shows variable rate of healingMin Hu, Robert F. Gagel, G. N. Hortobagyi et al.|Journal of Clinical Oncology|2007Cited by 0